APO-go (apomorphine continuous subcutaneous infusion) - Stada, Kyowa Kirin, Endo, Supernus Pharma
https://www.globenewswire.com/news-release/2024/05/08/2878228/19871/en/Supernus-Announces-First-Quarter-2024-Financial-Results.html
 
May 8, 2024
 
Next